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Purpose of the study
To describe some features of ART management in Albania,
as a limited resource country with low prevalence of HIV
infection, and compare with concurrent European
approach.
Methods
In the study are included 73 adult cases who are receiving
ART at Infectious Diseases (ID) Service in Tirana, Albania,
till May 2008. Since 2004 provision of ART started for the
first time in Albania. Therapy is delivered for all patients
in one center at ID Service in the capital, Tirana.
Summary of results
There are 45 male and 28 female HIV patients under ther-
apy. Resistance testing, HLA B 5701 screening testing and
Pap smear screening testing are not available as part of the
initial assessment of the patient. Criteria for initiation of
therapy include symptomatic patient and CD4 <200.
Most used first-line combinations are: ZDV/3TC + EFV in
40 adult patients and d4T + 3TC + EFV in 14 adult
patients. The preferred back-bone nucleotide combina-
tion is AZT + 3TC. NNRTI-based initial regimen is pre-
ferred, with EFV as the most preferred drug. The only PI
drug available in Albania is LPV/r which is used in six
patients for the second-line therapy in combination with
TNF and ddI.
Conclusion
Albania, as a country with low prevalence and limited
resources, is using a public health ART strategy. We think
that a better (if possible) strategy for ART management in
Albania would be a combination of public health and
individual approach.
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